Endocrine Board Review 2020 Meeting

This course is for active EBR 2020 registrants to complete the program evaluation and receive credit. The evaluation will be available starting September 18 following the live Q&A sessions.

Endocrine Board Review (EBR) is an essential course for endocrinologists preparing to take the boards or practicing physicians seeking an intensive knowledge assessment. The virtual program is designed as a mock exam, with rapid-fire case-based questions emulating the format and subject matter of the ABIM's Endocrinology, Diabetes, and Metabolism Certification Examination.

Learning Objectives

Upon completion of this virtual course, learners should be able to:

  • Demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology
  • Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders
  • Successfully complete the board examination for certification or re-certification in the subspeciality of endocrinology, diabetes, and metabolism.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
General Endocrinology
Hormone Abuse
Growth Disorders
Men’s Health
Neuroendocrinology and Pituitary
Nuclear Receptors and Steroid Hormones
Nutrition
Obesity
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 21.00 ABIM MOC
  • 21.00 AMA PRA Category 1 Credits
  • 21.00 CME Certificate of Participation
Course opens: 
09/16/2020
Course expires: 
12/31/2020
Rating: 
0

On-Demand Topical Mock Exam Presentations

Presentation TitleSpeaker
Adrenal Board ReviewTobias Else, MD
Calcium and Bone Board ReviewNatalie Cusano, MD, MS
Diabetes Board Review (Part 1)Serge A. Jabbour, MD
Diabetes Board Review (Part 2)Michelle F. Magee, MD
Female Reproduction Board ReviewKathryn A. Martin, MD
Male Reproduction Board ReviewFrances J. Hayes, MBBCh, BAO
Obesity/Lipids Board ReviewAndrea D. Coviello, MD
Pituitary Board ReviewLaurence Katznelson, MD
Thyroid Board ReviewJacqueline Jonklaas, MD, PhD, MPH

Live Topical Q&A Sessions

Day 1: Wednesday, September 16

Time Live Q&A Session
11:00 AM–12:00 PM EDT Diabetes Board Review (Part 1)
Serge A. Jabbour, MD
12:00–1:00 PM EDTPituitary Board Review
Laurence Katznelson, MD
1:00–2:00 PM EDTFemale Reproduction Board Review
Kathryn A. Martin, MD

Day 2: Thursday, September 17

TimeLive Q&A Session
11:00 AM–12:00 PM EDTObesity/Lipids Board Review
Andrea D. Coviello, MD
12:00–1:00 PM EDTDiabetes Board Review (Part 2)
Michelle F. Magee, MD
1:00–2:00 PM EDTAdrenal Board Review
Tobias Else, MD

Day 3: Friday, September 18

TimeLive Q&A Session
11:00 AM–12:00 PM EDTThyroid Board Review
Jacqueline Jonklaas, MD, PhD, MPH
12:00–1:00 PM EDTMale Reproduction Board Review
Frances J. Hayes, MBBCh, BAO
1:00–2:00 PM EDTCalcium and Bone Board Review
Natalie Cusano, MD, MS

EBR 2020 Faculty

Serge A. Jabbour, MD, Program Chair
Professor of Medicine
Director, Division of Endocrinology, Diabetes & Metabolic Diseases
Sidney Kimmel Medical College
Thomas Jefferson University

Andrea D. Coviello, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University School of Medicine

Natalie Cusano, MD, MS
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of the Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital

Tobias Else, MD
Associate Professor
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan

Frances J. Hayes, MB BCh, BAO
Clinical Director
Endocrine Division
Massachusetts General Hospital

Jacqueline Jonklaas, MD, PhD, MPH
Professor
Division of Endocrinology
Georgetown University Medical Center

Laurence Katznelson, MD
Professor of Neurosurgery and Medicine
Division of Endocrinology
Stanford University

Michelle F. Magee, MD
Director
MedStar Diabetes, Research and Innovation Institutes
Professor of Medicine
Georgetown University School of Medicine

Kathryn A. Martin, MD
Assistant Professor of Medicine
Harvard Medical School
Practicing Clinician
Massachusetts General Hospital
Senior Physician Editor, Endocrinology and Diabetes
UpToDate

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

Statement of Independence

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

Disclosures Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

EBR 2020 Faculty Disclosures

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Natalie Cusano, MD, MS, has served as a consultant to Shire/Takeda and Radius Pharmaceuticals and has served as a speaker for Shire/Takeda and Alexion.

Tobias Else, MD, has served as an advisory board member to Corcept Therapeutics and HRA Pharma, and his institution has received research support from Corcept Therapeutics, Merck and Strongbridge Biopharma.

Serge A. Jabbour, MD, has served as a consultant to AstraZeneca and Janssen, and his institution has received research support from the National Institutes of Health.

Laurence Katznelson, MD, has served as a consultant and principal investigator to Chiasma and Camarus, and he has served as an advisory board member to Novo Nordisk.

Michelle F. Magee, MD, receives research support from the NIH Diabetes Prevention Program Observational Study and the NIH Grade Study as an investigator on behalf of MedStar Health Research Institute. She serves as a speaker for the American Diabetes Association, the American College of Cardiology, and the Endocrine Society.  

Kathryn A. Martin, MD, has served as a physician editor for UpToDate.

The following faculty reported no relevant financial relationships: Andrea D. Coviello, MD; Frances J. Hayes, MB BCh, BAO; and Jacqueline Jonklaas, MD, PhD, MPH

The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMER

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment: 
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Continuing Medical Education (CME)

Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society designates this other activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21 MOC points in the American Board of Internal Medicine's (ABIM) MOC program. Participants will earn MOC points equivalent to the number of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

European Accreditation Council for Continuing Medical Education

The European Accreditation Council for Continuing Medical Education (EACCME) and the American Medical Association (AMA) signed an agreement of mutual recognition of CME credits between Europe and the USA whereby:

European physicians attending an event in the USA had their credits recognized in Europe and American physicians attending an event in Europe had their credits recognized in the USA.

The Endocrine Society designates this educational activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Each medical specialist should claim only those credits that he/she actually spent in the educational activity. These credits can be converted by the EACCME into European CME credits and/or into National credits by the European National Authorities.

Royal College of Physicians and Surgeons of Canada

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Available Credit

  • 21.00 ABIM MOC
  • 21.00 AMA PRA Category 1 Credits
  • 21.00 CME Certificate of Participation

For access to this course, you must have an active registration for EBR 2020, occurring between September 16-18, 2020. Upon completion of the online materials and live Q&A, you may complete your evaluation here.